Altimmune reports phase II extension study findings for NasoVAX intranasal influenza vaccine March 20, 2019
resTORbio announces plans for phase III program with RTB-101 for respiratory tract infections March 18, 2019
Allergy Therapeutics' phase III trial of adjuvanted birch allergoid product misses primary endpoint March 18, 2019
RSS